| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| JNJ 嬌生 | 270,782,985,893.56 | 1,858,121,290,561.13 | 6,509,903,919,877.75 |
| MRK 默克藥廠 | 314,902,279,016.5 | 1,284,042,894,992.83 | 4,378,064,952,026.99 |
| AMGN 美國安進 | 434,927,859,709.7 | 1,133,087,645,428.69 | 3,167,092,575,390.24 |
| NVO 諾和諾德 | 220,719,561,410.18 | 1,053,670,823,295.07 | 2,995,319,073,509.6 |
| BMY 施貴寶 | 315,693,656,471.62 | 981,538,862,773.21 | 2,927,173,310,246.36 |
| GILD 吉利德科學 | 212,254,028,275.31 | 545,819,625,608.39 | 1,695,130,508,867.04 |
| TEVA Teva Pharmaceutical Industries Limited | 120,520,191,602.65 | 453,723,074,268.8 | 1,314,247,134,529.91 |
| 1795 美時 | 7,259,021,000 | 26,577,483,000 | 111,129,063,000 |
| 6589 台康生技 | 2,952,816,000 | 4,131,149,000 | 11,211,846,000 |
| 6620 漢達 | 2,420,745,000 | 3,867,405,000 | 5,224,376,000 |
| 4166 友霖 | 633,559,000 | 1,405,726,000 | 3,123,845,000 |
| 6467 泰合 | 98,675,000 | 254,351,000 | 315,486,000 |
載入數據中...
和藥價與專利壓力相關的產業概念股
藥價與專利壓力概念股相關指標排名
藥價與專利壓力每月營收
藥價與專利壓力每股盈餘
藥價與專利壓力每股淨值
藥價與專利壓力損益表
藥價與專利壓力總資產
藥價與專利壓力負債和股東權益
藥價與專利壓力現金流量表
藥價與專利壓力利潤比率
藥價與專利壓力營業費用率拆解
藥價與專利壓力杜邦分析
藥價與專利壓力ROE / ROA
藥價與專利壓力經營週轉能力
藥價與專利壓力營運週轉天數
藥價與專利壓力現金股利發放率
藥價與專利壓力財務結構比率
藥價與專利壓力流速動比率
藥價與專利壓力利息保障倍數
藥價與專利壓力現金流量分析
藥價與專利壓力營業現金流對淨利比
藥價與專利壓力盈餘再投資比率
藥價與專利壓力月營收成長率
藥價與專利壓力營收成長率
藥價與專利壓力毛利成長率
藥價與專利壓力營業利益成長率
藥價與專利壓力稅後淨利成長率
藥價與專利壓力每股盈餘成長率
藥價與專利壓力本益比評價
藥價與專利壓力股價淨值比評價
藥價與專利壓力現金股利殖利率
藥價與專利壓力平均現金股息殖利率
藥價與專利壓力董監持股比例
藥價與專利壓力董監持股質押比例